Top compounds associated with response to RAPGEF4


Feature Type Standardized
Nominal ANOVA
mRNA ML083 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.11 0.003
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.1 0.003
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.1 0.003
mRNA Midostaurin GDSC1000 pan-cancer AAC -0.1 0.003
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.095 0.004
mRNA lovastatin CTRPv2 pan-cancer AAC -0.11 0.004
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA pluripotin CTRPv2 pan-cancer AAC -0.1 0.004
Download CSV